Take a look at the portfolio of investments that the Bioscience Managers Translation Fund 1, speculative biotech plays I'm sure they weren't involved in final investment decision but a current ACR NED, Brooke and a former ACR NED, Green are partners in the organisation.
I'd liked to know the thinking of the 2 ex-substantial holders and why they were happy to let some-one else invest and not increase there positions.
Add to My Watchlist
What is My Watchlist?
